Switching Study From Warfarin to Rivaroxaban

NCT01507051 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thrombosis

Interventions

DRUG: Warfarin (Coumadin)
DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Placebo
DRUG: Vitamin K (Konakion)

Sponsor

Bayer

Collaborators

[object Object]